Lv0
0 积分 2025-03-18 加入
Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis
2天前
已完结
Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial
1个月前
已完结
颈纹非手术治疗方法的研究进展
2个月前
已完结
Efficacy and Safety of Cross-Linked Sodium Hyaluronate for the Treatment of Moderate-to-Severe Neck Wrinkles: A Prospective, Multicenter, Randomized, Single-Blind Clinical Trial
3个月前
已关闭
Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder
4个月前
已关闭
阿尔茨海默病精神行为症状的机制及其干预研究进展
4个月前
已完结
阿尔茨海默病中精神行为症状的研究进展
4个月前
已完结
Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study
5个月前
已完结
Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
6个月前
已关闭
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)
6个月前
已完结
皖公网安备34019202002308
